Clinical trial

Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC

NCT01528488

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2013-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

EVOZAC Calming Skin SprayOTHER

Physiological salineOTHER

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01528488 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.